Literature DB >> 25316843

Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and enhanced community surveillance, 2009.

Ondrej Mach1, Harish Verma2, Devendra W Khandait2, Roland W Sutter3, Patrick M O'Connor4, Mark A Pallansch1, Stephen L Cochi1, Robert W Linkins1, Susan Y Chu1, Chris Wolff3, Hamid S Jafari2.   

Abstract

BACKGROUND: In 2009, enhanced poliovirus surveillance was established in polio-endemic areas of Uttar Pradesh and Bihar, India, to assess poliovirus infection in older individuals.
METHODS: In Uttar Pradesh, stool specimens from asymptomatic household and neighborhood contacts of patients with laboratory-confirmed polio were tested for polioviruses. In Bihar, in community-based surveillance, children and adults from 250 randomly selected households in the Kosi River area provided stool and pharyngeal swab samples that were tested for polioviruses. A descriptive analysis of surveillance data was performed.
RESULTS: In Uttar Pradesh, 89 of 1842 healthy contacts of case patients with polio (4.8%) were shedding wild poliovirus (WPV); 54 of 85 (63.5%) were ≥5 years of age. Shedding was significantly higher in index households than in neighborhood households (P<.05). In Bihar, 11 of 451 healthy persons (2.4%) were shedding WPV in their stool; 6 of 11 (54.5%) were ≥5 years of age. Mean viral titer was similar in older and younger children.
CONCLUSIONS: A high proportion of persons≥5 years of age were asymptomatically shedding polioviruses. These findings provide indirect evidence that older individuals could have contributed to community transmission of WPV in India. Polio vaccination campaigns generally target children<5 years of age. Expanding this target age group in polio-endemic areas could accelerate polio eradication.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  India; community transmission; enhanced surveillance; poliomyelitis

Mesh:

Year:  2014        PMID: 25316843      PMCID: PMC4663665          DOI: 10.1093/infdis/jit234

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.

Authors:  Concepción F Estívariz; Hamid Jafari; Roland W Sutter; T Jacob John; Vibhor Jain; Ashutosh Agarwal; Harish Verma; Mark A Pallansch; Ajit P Singh; Sherine Guirguis; Jitendra Awale; Anthony Burton; Sunil Bahl; Arani Chatterjee; R Bruce Aylward
Journal:  Lancet Infect Dis       Date:  2011-11-07       Impact factor: 25.071

2.  A CONTINUING SURVEILLANCE OF ENTEROVIRUS INFECTIONS IN HEALTHY CHILDREN IN SIX UNITED STATES CITIES. I. VIRUSES ISOLATED DURING 1960 AND 1961.

Authors:  H M GELFAND; A H HOLGUIN; G E MARCHETTI; P M FEORINO
Journal:  Am J Hyg       Date:  1963-11

3.  Studies on the development of natural immunity to poliomyelitis in Louisiana. I. Over-all plan, methods and observations as to patterns of seroimmunity in the study group.

Authors:  J P FOX; H M GELFAND; D R LEBLANC; D P CONWELL
Journal:  Am J Hyg       Date:  1957-05

4.  Progress towards poliomyelitis eradication in India, 2003.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2004-03-26

5.  New strategies for the elimination of polio from India.

Authors:  Nicholas C Grassly; Christophe Fraser; Jay Wenger; Jagadish M Deshpande; Roland W Sutter; David L Heymann; R Bruce Aylward
Journal:  Science       Date:  2006-11-17       Impact factor: 47.728

6.  Progress towards poliomyelitis eradication: India, January 2006-September 2007.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-11-16

Review 7.  Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission.

Authors:  Hiromasa Okayasu; Roland W Sutter; Cecil Czerkinsky; Pearay L Ogra
Journal:  Vaccine       Date:  2011-09-05       Impact factor: 3.641

8.  Environmental surveillance system to track wild poliovirus transmission.

Authors:  Jagadish M Deshpande; Sushmitha J Shetty; Zaeem A Siddiqui
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

9.  Mucosal immunity following oral poliovirus vaccine and enhanced potency inactivated poliovirus vaccine immunization.

Authors:  J F Modlin
Journal:  Pediatr Infect Dis J       Date:  1991-12       Impact factor: 2.129

10.  Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study.

Authors:  Nicholas C Grassly; Jay Wenger; Sunita Durrani; Sunil Bahl; Jagadish M Deshpande; Roland W Sutter; David L Heymann; R Bruce Aylward
Journal:  Lancet       Date:  2007-04-21       Impact factor: 79.321

View more
  3 in total

1.  Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014-April 2016.

Authors:  George Shirreff; Mufti Zubair Wadood; Rui Gama Vaz; Roland W Sutter; Nicholas C Grassly
Journal:  Emerg Infect Dis       Date:  2017-02-15       Impact factor: 6.883

2.  Non-polio enteroviruses among healthy children in the Philippines.

Authors:  Maria Melissa Ann Jiao; Lea Necitas Apostol; Maricel de Quiroz-Castro; Youngmee Jee; Vito Roque; Manuel Mapue; Frances Marsha Navarro; Cleo Fe Tabada; Amado Tandoc
Journal:  BMC Public Health       Date:  2020-02-03       Impact factor: 3.295

3.  Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.

Authors:  Jonathan Altamirano; Natasha Purington; Rasika Behl; Clea Sarnquist; Marisa Holubar; Lourdes García-García; Leticia Ferreyra-Reyes; Rogelio Montero-Campos; Luis Pablo Cruz-Hervert; Shanda Boyle; John Modlin; Christopher van Hoorebeke; Sean Leary; ChunHong Huang; Marvin Sommer; Elizabeth Ferreira-Guerrero; Guadalupe Delgado-Sanchez; Sergio Canizales-Quintero; José Luis Díaz Ortega; Manisha Desai; Yvonne A Maldonado
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.